On Jul. 5, 2021, CerTest Biotec and BD announces addition of saliva to the CE Marked VIASURE SARS-CoV-2 (N1+N2) real time PCR detection kit for BD MAX molecular diagnostic system.

This allows BD MAX™ System users more flexibility with three alternatives for specimen collection: nasopharyngeal, oropharyngeal and saliva. This kit, CE marked to the IVD Directive (98/79/CE), detects all currently identified variants of SARS-CoV-2.

As the COVID-19 pandemic continues to impact Europe with additional lockdowns planned in some countries, the ability to test an ample portion of the population and identify infected people is critical to helping contain the spread and limit additional waves of the disease.